Biological E. Limited
- All
- News
-
Vaccine For 12-14 Age Group: Delhi Parents Feel Relieved, Say Apt Move Ahead Of School Reopening
The COVID-19 vaccine to be administered to the 12-14 years age group would be Corbevax manufactured by Biological E. Limited, Hyderabad.
-
Biological E Aims To Produce 100 Million Doses Of Corbevax Every Month From Feb 2022
Biological E. Limited plans to complete production at a rate of 75 million doses of its COVID-19 vaccine Corbevax per month, anticipating over 100 million doses per month from February 2022.
-
Hyderabad's Biological E Expects To Rollout Corbevax Covid Vaccine By November-End
Biological E. Limited (BE) is expecting its COVID-19 vaccine Corbevax to be rolled out by the end of November even as the city-based firm is getting ready with 100 million doses for the launch, Mahima Datla, Managing Director, BE said on Monday.
-
Vaccine For 12-14 Age Group: Delhi Parents Feel Relieved, Say Apt Move Ahead Of School Reopening
The COVID-19 vaccine to be administered to the 12-14 years age group would be Corbevax manufactured by Biological E. Limited, Hyderabad.
-
Biological E Aims To Produce 100 Million Doses Of Corbevax Every Month From Feb 2022
Biological E. Limited plans to complete production at a rate of 75 million doses of its COVID-19 vaccine Corbevax per month, anticipating over 100 million doses per month from February 2022.
-
Hyderabad's Biological E Expects To Rollout Corbevax Covid Vaccine By November-End
Biological E. Limited (BE) is expecting its COVID-19 vaccine Corbevax to be rolled out by the end of November even as the city-based firm is getting ready with 100 million doses for the launch, Mahima Datla, Managing Director, BE said on Monday.
